Slurricane is an indica cannabis strain made by intersection Do-Si-Dos with Purple Punch. Slurricane produces loosening up impacts that please leisurely. This strain has a sweet flavor profile, with inconspicuous grape and sweet berries.
Slurricane is the best strain for unwinding in the wake of a monotonous day and will probably leave you bolted to your couch. Clinical weed patients pick this strain to assist with soothing manifestations related to sleep deprivation.
Indica Dominant Hybrid – 60% Indica/40% Sativa
THC: 20% – 28%
Slurricane is a marginally indica predominant half and half strain (60% indica/40% sativa) made through a powerful cross of the flavorful Do-Si-Dos X Purple Punch strains. In case you’re an indica darling who likes a very tasty toke and an intense punch of impacts, look no further – Slurricane will absolutely have you shocked with its heavenly blend.
This bud packs a very sweet fruity berry flavor complemented by zesty tropical leafy foods upon breath out. The smell takes an impactful turn, with a hot gritty hint that is complemented by spices and berries.
The Slurricane high gets comfortable a couple of moments after your first delectable breathe out, crawling up on the rear of your head with shivery impacts before unexpectedly grabbing hold.
You’ll feel taking off elation develop and develop, filling you with a far-reaching satisfaction that pushes out any regrettable considerations. A strong body high comes straightaway, quieting you into a totally love seat bolted express that has you absolutely undaunted for quite a long time on end.
On account of these impacts and its very powerful 20-28% normal THC level, Slurricane is the ideal decision for treating patients experiencing headaches or migraines persistent agony, issues or muscle fits, and ongoing exhaustion. This bud has feathery grape-molded curiously large dull olive green nugs with rich purple undercurrents, meager golden hairs, and a covering of purple-colored minuscule white gem trichomes.
Effects of Slurricane-
There are no reviews yet.